Megan Thomas

United Kingdom

Multimedia Editor at The Drug Discovery World Podcast

Featured in: Favicon

ddw-online.com

Articles

How is precision medicine making its mark in drug discovery?

1 week ago | ddw-online.com | Megan Thomas

This is the latest episode of the free DDW narrated podcast, titled “Innovation enabled by new drug discovery technologies”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Accelerating biotherapy and personalised medicine with long DNA” and “The microbiome in precision medicine”.
New podcast: Getting to know key drug discovery leaders and researchers

2 weeks ago | ddw-online.com | Megan Thomas

This is the latest episode of the free DDW narrated podcast, titled “Innovation enabled by new drug discovery technologies”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Sitting down with… Neil Dhawan”, “Meet the researcher: Giusy Di Conza, iOnctura” and “From the Top: Adele Hannigan, Antibody Analytics”.
Podcast: Where is the innovation and opportunity in the therapeutic antibody market?

3 weeks ago | ddw-online.com | Megan Thomas

This is the latest episode of the free DDW narrated podcast, titled “Innovation enabled by new drug discovery technologies”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023.
New DDW Highlights podcast: 31 March 2025

3 weeks ago | ddw-online.com | Megan Thomas

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Weight loss drugs have been making the news this week. As we come to the end of Women’s History Month, two of the covered studies focus on women’s health, specifically the role of weight loss drugs in treating endometriosis and why women have worse side effects from these therapeutics.
DDW Highlights: 31 March 2025

3 weeks ago | ddw-online.com | Megan Thomas

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Weight loss drugs have been making the news this week. As we come to the end of Women’s History Month, two of the covered studies focus on women’s health, specifically the role of weight loss drugs in treating endometriosis and why women have worse side effects from these therapeutics.
Gene therapy landmark in haemophilia B

4 weeks ago | ddw-online.com | Megan Thomas

Following the news that the first patients in Denmark with haemophilia B had been treated with Hemgenix (etranacogene dezaparvovec) gene therapy since European Commission approval, DDW’s Megan Thomas spoke with Dr Fredrik Sjöö, Head of Medical Affairs in the Nordic Region at CSL Behring, as well as Radovan Tomic, Global Market Access Director at CSL Behring. MT: What does the treatment of patients with Hemgenix signify for the broader adoption of gene therapy in haemophilia B?
Innovation enabled by new drug discovery technologies

4 weeks ago | ddw-online.com | Megan Thomas

This is the latest episode of the free DDW narrated podcast, titled “Innovation enabled by new drug discovery technologies”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “CRISPR breakthroughs: New solutions for common diseases” and “Re-assessing the risks of drug-induced arrhythmias during drug discovery”.
Phase II study in metastatic uveal melanoma commences

1 month ago | ddw-online.com | Megan Thomas

iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, has dosed the first patient in the randomised Phase II OCULE-01 study investigating lead asset roginolisib in patients with metastatic uveal melanoma (UM), a rare cancer of the eye. Roginolisib is an orally dosed small molecule allosteric modulator of PI3Kδ.
Mounjaro’s role in managing endometriosis

1 month ago | ddw-online.com | Megan Thomas

Endometriosis is a chronic and often debilitating condition affecting one in 10 women in the UK. Weight management and metabolic health play an essential role in symptom control. The weight loss drug Mounjaro (tirzepatide) and its effects on appetite regulation, insulin sensitivity, and weight loss, could be an unexpected tool for some individuals managing the condition.
New DDW Highlights podcast: 24 March 2025

1 month ago | ddw-online.com | Megan Thomas

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week the DDW news round-up takes a look at developments in cancer research, including AZ’s acquisition of EsoBiotec, positive trial results for an allogeneic T-cell therapy, and a new drug target for glioblastoma.